The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study-Reference-Cited by-同舟云学术

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study

Published:2018-01-18 Issue:2 Volume:24 Page:394-401
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Macaluso Fabio Salvatore¹,Sapienza Chiara¹,Ventimiglia Marco¹,Renna Sara¹,Rizzuto Giulia¹,Orlando Rosalba¹,Di Pisa Marta²,Affronti Marco¹,Orlando Emanuele¹,Cottone Mario¹,Orlando Ambrogio¹

Affiliation:

1. Division of Internal Medicine, University of Palermo, Italy

2. Gastroenterology and Endoscopy Unit, ‘‘Villa Sofia-Cervello’’ Hospital, Palermo, Italy

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/24/2/394/24616093/izx010.pdf

Reference29 articles.

1. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease;Orlando;Dig Liver Dis,2011

2. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease;Vermeire;Gut,2007

3. Infliximab, azathioprine, or combination therapy for Crohn’s disease;Colombel;N Engl J Med,2010

4. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis;Panaccione;Gastroenterology,2014

5. Effects of combination therapy with immunomodulators on trough levels and antibodies against tumor necrosis factor antagonists in patients with inflammatory bowel disease: a meta-analysis;Qiu;Clin Gastroenterol Hepatol,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis;Digestive Diseases and Sciences;2024-06-14

2. An in vitro study elucidating the synergistic effects of aqueous cinnamon extract and an anti-TNF-α biotherapeutic: implications for a complementary and alternative therapy for non-responders;BMC Complementary Medicine and Therapies;2024-03-23

3. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01

4. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review;World Journal of Gastroenterology;2023-08-07

5. The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBD;Journal of Clinical Medicine;2023-06-29